Who owns AMGEN INC (AMGN)? Elite investor 13F holders
12 tracked elite investors reported holding AMGEN INC as of 2026-06-30, including Aristotle Capital Management, D.E. Shaw, Matrix Asset Advisors, Torray Funds, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
12 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Aristotle Capital Management | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1055695252.00 USD | 2915257.000000 | Shares | reduce | Original filing |
| D.E. Shaw | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 467213380.00 USD | 1290217.000000 | Shares | add | Original filing |
| Matrix Asset Advisors | AMGEN INC | SHARE | 2026-06-30 | 2026-07-15 00:00:00 | 37231920.00 USD | 102817.000000 | Shares | add | Original filing |
| Torray Funds | AMGEN INC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 21644275.00 USD | 59771.000000 | Shares | add | Original filing |
| Gotham Asset Management | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 16875154.00 USD | 46601.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12542814.00 USD | 34637.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 7919202.00 USD | 21869.000000 | Shares | add | Original filing |
| Dodge & Cox Funds | AMGEN INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 4641292.00 USD | 12817.000000 | Shares | reduce | Original filing |
| Mairs & Power Funds | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1783079.00 USD | 4924.000000 | Shares | reduce | Original filing |
| GAMCO | AMGEN INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 1672270.00 USD | 4618.000000 | Shares | reduce | Original filing |
| Check Capital Management | AMGEN INC | SHARE | 2026-06-30 | 2026-08-03 00:00:00 | 1406836.00 USD | 3885.000000 | Shares | hold | Original filing |
| East Coast Asset Management | AMGEN INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 589531.00 USD | 1628.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.